The ratio of CD4+ to CD8+ cells in the tumor mesenchymal tumor component was also distinct, with the high NF-κB expressers having a higher mesenchymal CD4+/CD8+ ratio (Fig. 3J). This evidence concerns the gene CD8A and neoplasm.